NCT00100243 - Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

September 30, 2005

Conditions

Prostate Cancer

Interventions

DRUG

Plenaxis

Trial Locations (7)

Carolina Urologic Research Center, Myrtle Beach

Panama City Urological Center, Panama City

Southwest Florida Urological Associates, Fort Myers

Columbus Urology Research, LLC, Columbus

San Diego Center for Urology, La Mesa

Oregon Health & Science University, Portland

Urological Associates of Lancaster, Lancaster